ATAIATAI Life Sciences N.V. Common Shares

7.380USD+0.27%Mkt Cap: 2.74B $P/E:

AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-00…

Key Statistics

Company
Market Cap2.74B $
Enterprise Value2.52B $
Revenue (TTM)4.47M $
Gross Profit-70.62M $
Net Income (TTM)-660.05M $
Revenue/Share0.0140 USD
Last Price7.380 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-15.14
PEG
EV/EBITDA-17.93
EV/Revenue564.58
P/S615.34
P/B15.52
EPS (TTM)-2.79
EPS (Forward)-0.49
52W Range
7.24067% of range7.450
52W High7.450 USD
52W Low7.240 USD
Profitability
Gross Margin0.00%
Oper. Margin-2590.43%
EBITDA Margin0.00%
Profit Margin-16142.02%
ROE-297.49%
ROA-225.49%
Growth
Revenue Growth137.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-102.67M $
CapEx (TTM)10.87M $
FCF Margin-1669.72%
FCF Yield-2.73%
Net Debt-221.52M $
Net Debt/EBITDA1.57
Balance Sheet
Debt/Equity0.01
Current Ratio8.58
Quick Ratio8.29
Book Value/Sh0.4780 USD
Cash/Share0.6090 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating2.9 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.100 USD
Upside (mean)+9.8%
Target Range7.450 USD9.250 USD
$7.450+9.8% to mean$9.250
# Analysts7
Ownership
Shares Out.370.86M
Float308.41M
Insiders2.18%
Institutions53.03%
Short Interest
Short Ratio1.0d
Short % Float6.33%
Short % Out.5.37%
Shares Short19.86M
Short (prev mo.)30.26M
Technical
SMA 505.999 (+23.0%)
SMA 2004.506 (+63.8%)
Beta1.55
S&P 52W Chg18.16%
Avg Vol (30d)6.98M
Avg Vol (10d)6.41M
Technical Indicators
RSI (14)73.0
MACD0.3172
MACD Signal0.3864
MACD Hist.-0.0692
BB Upper7.385 USD
BB Middle7.239 USD
BB Lower7.094 USD
BB Width4.03%
ATR (14)0.1231 USD
Vol Ratio (20d)0.49x